Inhalation Sciences Sweden
0.23 SEK
+0.87 %
Less than 1K followers
ISAB
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Inhalation Sciences Sweden
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3 | 1.5 | 11.1 | 0.8 | 0.8 | 0.2 | 1.3 | 3.0 |
| EBITDA | -0.7 | -3.3 | -5.1 | -2.1 | -2.4 | -2.7 | -2.6 | -9.7 |
| EBIT | -1.0 | -2.4 | -5.1 | -2.2 | -2.5 | -2.8 | -2.7 | -10.2 |
| EBIT-% | -43.9 % | -161.7 % | -46.0 % | -276.5 % | -320.5 % | -1,731.3 % | -204.6 % | -333.9 % |
| Profit before taxes | -1.0 | -2.4 | -5.2 | -2.3 | -2.5 | -2.8 | -2.6 | -10.2 |
| Net income | -1.0 | -2.4 | -5.2 | -2.3 | -2.5 | -2.8 | -2.6 | -10.2 |